Joel Morris
4PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 17, 2025
RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types.Zahra Davoudi, Thomas S Dexheimer, Nathan P Coussens
|Jun 11, 2024
HTS384 NCI60: The Next Phase of the NCI60 Screen.Mark W Kunkel, Nathan P Coussens, Joel Morris
|Aug 28, 2023
Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs.Thomas S Dexheimer, Nathan P Coussens, Thomas Silvers
|Aug 07, 2023
Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource.Joel Morris, Mark W Kunkel, Stephen L White
Pageof 1
Frequent Collaborators
4 joint publications
Beverly A Teicher
4 joint publications
James H Doroshow
4 joint publications
Nathan P Coussens
4 joint publications
Thomas S Dexheimer
2 joint publications
Mark W Kunkel
2 joint publications
Thomas Silvers
1 joint publications
Stephen L White
1 joint publications
Donn G Wishka
1 joint publications
Lori Bowles
1 joint publications
Penny Sellers Brady
